Rogier Heide, Maritza A. Middelkamp Hup, Paul G. H. Mulder, Arnold P. Oranje
DOI: 10.1080/00015550152572912

There are still many controversies in defining and evaluating mastocytosis. One of the aspects that is missing is a system for clinical evaluation of mastocytosis of the skin. A calculation based on a semi-quantitative analysis of three aspects of mastocytosis was designed. The method is called the scoring index of mastocytosis (SCORMA). The clinical use of SCORMA is advocated.